US OptionsDetailed Quotes
MESO241220P7000
- 0.30
- 0.000.00%
15min DelayTrading Nov 21 13:15 ET
0.00High0.00Low
0.00Open0.30Pre Close0 Volume67 Open Interest7.00Strike Price0.00Turnover171.22%IV38.81%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.30Extrinsic Value100Contract SizeAmericanOptions Type-0.1061Delta0.0379Gamma36.50Leverage Ratio-0.0182Theta-0.0009Rho-3.87Eff Leverage0.0052Vega
Mesoblast Stock Discussion
Sign in to post a comment
$Mesoblast (MESO.US)$ …got approval from FDA??
1
$Mesoblast (MESO.US)$ How low will it go?
1
1
$Mesoblast (MESO.US)$ … today back to 10
1
7
$Mesoblast (MESO.US)$ .. will drop then rocket by end of this year
1
2
$Mesoblast (MESO.US)$
Mesoblast Option to Issue Up to US$50 Million Convertible Notes for Product Launch | MESO Stock News
Mesoblast Option to Issue Up to US$50 Million Convertible Notes for Product Launch | MESO Stock News
1
1
$Mesoblast (MESO.US)$ .. if below to 5.. nice to buy!!!
2
4
$Mesoblast (MESO.US)$ Mesoblast (MESO) has released an update. Mesoblast Limited has resubmitted a Biologics License Application (BLA) to the FDA for Ryoncil®, aiming to treat children with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD). The resubmission, buoyed by promising Phase 3 study results demonstrating significant survival benefits, could meet an urgent need for effective treatment in this patient group, as current survival outcomes are poor and no FDA-approved treatm...
2
8
$Mesoblast (MESO.US)$ which is developing off-the-shelf cellular medicines for life-threatening inflammatory conditions, is planning to file a Biologics License Application for Ryoncil with the FDA next week.
2
2
No comment yet
Aariya : may be almost there or already done but not yet published